Our Medical Advisory Board, chaired by Prof. Andrew Rice, brings together globally recognized clinical scientists and pain specialists, and will enable us to rapidly execute on our shared mission of building a strong pipeline of high-value GPCR modulators derived from our pioneering drug discovery platform.